165 related articles for article (PubMed ID: 22294695)
1. Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages.
Zeitvogel J; Dalpke A; Eiz-Vesper B; Kracht M; Dittrich-Breiholz O; Werfel T; Wittmann M
J Biol Chem; 2012 Mar; 287(13):9923-9930. PubMed ID: 22294695
[TBL] [Abstract][Full Text] [Related]
2. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of suppressor of cytokine signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20 receptor-related cytokines.
Uto-Konomi A; Miyauchi K; Ozaki N; Motomura Y; Suzuki Y; Yoshimura A; Suzuki S; Cua D; Kubo M
PLoS One; 2012; 7(7):e40343. PubMed ID: 22792286
[TBL] [Abstract][Full Text] [Related]
4. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
5. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
[TBL] [Abstract][Full Text] [Related]
6. IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells.
Bluyssen HA; Rastmanesh MM; Tilburgs C; Jie K; Wesseling S; Goumans MJ; Boer P; Joles JA; Braam B
Am J Physiol Cell Physiol; 2010 Aug; 299(2):C354-62. PubMed ID: 20484656
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
[TBL] [Abstract][Full Text] [Related]
9. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
10. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes.
Wittmann M; Zeitvogel J; Wang D; Werfel T
J Allergy Clin Immunol; 2009 Jul; 124(1):81-9. PubMed ID: 19523673
[TBL] [Abstract][Full Text] [Related]
11. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.
Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S
J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976
[TBL] [Abstract][Full Text] [Related]
12. Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by
Duncan SA; Sahu R; Dixit S; Singh SR; Dennis VA
Mediators Inflamm; 2020; 2020():7461742. PubMed ID: 32684836
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
14. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
16. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
17. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.
Qin H; Yeh WI; De Sarno P; Holdbrooks AT; Liu Y; Muldowney MT; Reynolds SL; Yanagisawa LL; Fox TH; Park K; Harrington LE; Raman C; Benveniste EN
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5004-9. PubMed ID: 22411837
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta promotes Th17 cell development through inhibition of SOCS3.
Qin H; Wang L; Feng T; Elson CO; Niyongere SA; Lee SJ; Reynolds SL; Weaver CT; Roarty K; Serra R; Benveniste EN; Cong Y
J Immunol; 2009 Jul; 183(1):97-105. PubMed ID: 19535626
[TBL] [Abstract][Full Text] [Related]
19. SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.
Madonna S; Scarponi C; Morelli M; Sestito R; Scognamiglio PL; Marasco D; Albanesi C
Oncotarget; 2017 Apr; 8(15):24652-24667. PubMed ID: 28445952
[TBL] [Abstract][Full Text] [Related]
20. Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M.
Kanda N; Watanabe S
Immunobiology; 2012 Apr; 217(4):436-45. PubMed ID: 22137028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
